Communicable Disease
COVID Vaccine: How Effective Are They Against Variants?
COVID Vaccine: How Effective Are They Against Variants? …
TAG
May 3, 2022
COVID Vaccine: How Effective Are They Against Variants? …
Key Points: In today’s Recommendations for Industry, we discuss low COVID levels across much of the U.S. with some regional levels of BA.2.12. Read more
Key Points: In today’s Recommendations for Industry, we discuss the dropping of the travel mask mandate. Read more below. Declaring the COVID-19 travel mask mandate
Key Points: In today’s Recommendations for Industry, we discuss the current status of COVID and the conflicting news. Read more below. The CDC has extended
Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant.
Key Points: In today’s Recommendations for Industry, we discuss the flattening of global COVID cases. Read more below. Asian COVID hot spots show signs of
Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss the impact of the national COVID plans on workforce decision-making. Read more below. White House Releases
Key Points: In today’s Recommendations for Industry, we discuss CDC’s new masking guidance and the utilization of the County-Searchable Tool. Read more below. A recent
Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly COVID matrix and its indicators for endemic vs. pandemic and related masking requirements. Read
